F2987-PD-PSYCHFNC
15 - Item Geriatric Depression Scale (GDS-15)
15 - Item Geriatric Depression Scale (GDS-15) is a shorter version the GDS to facilitate assessment in primary care, hospital, and home settings. Developed to screen for depression without notable focus on somatic symptoms. Items are geared to assess psychological symptoms and cognitive complaints associated with depression. The tool was designed with a simple Yes/No format for responses to limit resistance towards psychiatric assessments or interventions in older adults.
N/A
1.00
2022-04-29 16:25:33.0
Parkinson's Disease
Parkinson's Disease
F3001-PD-MOTORFNC
Abnormal Involuntary Movement Scale (AIMS)
The Abnormal Involuntary Movement Scale (AIMS) is a clinician-rated outcome used to assess the severity of abnormal movements in different parts of the body. It measures the presence and severity of the abnormal facial and oral movements, abnormal movements in the extremities, and truncal abnormal movements, the global severity of the abnormal movements, the disability derived from the abnormal movements, and patient?s awareness of the abnormal movement. Dental hygiene and wearing of dentures are also assessed.
N/A
1.00
2022-05-02 10:09:04.0
Parkinson's Disease
Parkinson's Disease
F2964-PD-OTHNONMT
Actigraphy (with Sleep Diary)
Established clinical practice guidelines for actigraphy from the American Academy of Sleep Medicine (AASM) International Classification of Sleep Disorders (ICSD) ? Third Edition. It is recommended that the participant wear the device while filling in a daily sleep diary.
N/A
1.00
2022-04-29 14:20:33.0
Parkinson's Disease
Parkinson's Disease
F2410-PD-COGNITVE
Addenbrooke's Cognitive Examination-III (ACE-III)
N/A
1.00
2017-03-16 17:40:55.0
Parkinson's Disease
Parkinson's Disease
F1653-PD-COGNITVE
Alzheimer's Disease Assessment Scale-Cognition (ADAS-cog)
N/A
1.00
2013-11-14 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F2988-PD-PSYCHFNC
Apathy Motivation Index (AMI)
The Apathy Motivation Index (AMI) is an 18 item self-report index that assesses apathy in the behavioral activation (BA), emotional sensitivity (ES), and social motivation (SM) domains over the previous two weeks. It was adapted from the Lille Apathy Rating Scale (LARS).
N/A
1.00
2022-04-29 16:29:26.0
Parkinson's Disease
Parkinson's Disease
F2989-PD-PSYCHFNC
Apathy Motivation Index Caregiver Version (AMI-CG)
The Apathy Motivation Index Caregiver Version (AMI-CG) is an 18 item caregiver reported index that assesses apathy in the behavioral activation (BA), emotional sensitivity (ES), and social motivation (SM) domains over the previous two weeks. It was adapted from the Lille Apathy Rating Scale (LARS).
N/A
1.00
2022-04-29 16:30:59.0
Parkinson's Disease
Parkinson's Disease
F2806-PD-PSYCHFNC
Apathy Scale (AS)
The Apathy Scale is an abridged version of the Apathy Evaluation Scale (Marin, 1990). The AS consists of 14 items regarding different dimensions of apathetic behavior. The score for each item ranges from 0 to 3. Rating of each item is based on a semi-structured interview: each question should be read by the examiner, and the patient is provided with the four possible answers.
CDE Details
1.00
2012-06-25 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F3041-PD-PSYCHFNC
Beck Depression Inventory II (BDI-II)
The BDI-II was developed in 1996 and was derived from the BDI. The 21-item survey is self-administered and is scored on a scale of 0-3 in a list of four statements arranged in increasing severity about a particular symptom of depression, bringing the BDI-II into alignment with DSM-IV criteria.
CDE Details
1.00
2012-01-16 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F0781-PD-OTHNONMT
Berlin Questionnaire
Contains data elements that assess that participant/subject's risk for having sleep apnea. (Examples of CDEs included: Do you snore; How often do you feel tired or fatigued; etc.)
N/A
1.00
2011-02-28 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F3012-PD-DIGTTECH
Best Practices for Digital Health Outcomes
Best practices for choice of connected sensor technology (digital technology) for digital health outcome measures for clinical research on Parkinson?s disease
N/A
1.00
2022-05-09 11:52:16.0
Parkinson's Disease
Parkinson's Disease
F2990-PD-PSYCHFNC
Brief Dimensional Apathy Scale (b-DAS)
The brief Dimensional Apathy (b-DAS) is a 9-item short form of the informant/carer-rated DAS that measures apathy over the last month in three subscales: executive, emotional, and initiation behavior. This scale also includes an assessment of the patient?s awareness of specific difficulties.
N/A
1.00
2022-04-29 16:35:05.0
Parkinson's Disease
Parkinson's Disease
F3042-PD-OTHNONMT
Brief Pain Inventory (BPI) Short Form
One of the most widely used measurement tools for assessing clinical pain; shown to be an appropriate measure for pain caused by a wide range of clinical conditions
CDE Details
1.00
2012-05-14 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F0803-PD-PSYCHFNC
Brief Psychiatric Rating Scale (BPRS)
The Brief Psychiatric Rating Scale (BPRS) is used to assess patients who display symptoms of schizophrenia and other psychotic disorders. It has been widely used in Parkinson's disease psychiatric clinical trials and is the easiest/shortest to administer. The instrument should be used in cognitively intact participants and does not require an informant.
CDE Details
1.00
2012-05-14 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F1656-PD-OTHNONMT
Brief Smell Identification Test (Brief-SIT)
N/A
1.00
2013-11-14 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F1657-PD-COGNITVE
Cambridge Cognitive Examination-Revised (CAMCOG-R)
The Cambridge Cognitive Examination-Revised (CAMCOG-R) measures severity of cognitive impairment in the elderly. Domains tested are: orientation, language, memory, attention and calculation, praxis, abstraction and perception.
N/A
1.00
2013-11-14 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F2396-PD-COGNITVE
Cambridge Neuropsychological Test Automated Battery (CANTAB)
CANTAB contains a total of 25 cognitive tasks, each loading onto specific cognitive domains across memory, attention, executive function, social cognition, psychomotor and processing speed. Individual tests can be grouped together to create a battery relevant for particular research. Computer administered cognitive test battery which uses non-verbal visual stimuli and is culturally neutral. The constructs measured by this test are attention, executive functioning and memory.
N/A
1.00
2017-03-08 10:16:33.0
Parkinson's Disease
Parkinson's Disease
F2958-PD-COGNITVE
Cambridge Neuropsychological Test Automated Battery (CANTAB) Connect
The Cambridge Neuropsychological Test Automated Battery (CANTAB) Connect Research web-based testing platform aims to enrich cognitive research by enabling sensitive cognitive measures to be captured from subjects on a global scale. The four recommended tests for Parkinson's disease cover episodic memory, recognition memory, executive abilities, and working memory.
N/A
1.00
2022-04-29 13:56:40.0
Parkinson's Disease
Parkinson's Disease
F2397-PD-COGNITVE
CDR System
The Cognitive Drug Research computerized cognitive assessment system (CDR System) is an integrated set of cognitive tasks, developed in the 1980s to provide a practical, sensitive, reliable and repeatable method of assessing core aspects of cognitive function in healthy volunteers and any patient population.
N/A
1.00
2017-03-08 10:28:28.0
Parkinson's Disease
Parkinson's Disease
F3002-PD-MOTORFNC
Clinical Global Impression Scale-Improvement (CGI-I)
The Clinical Global Impression Scale-Improvement (CGI-I) is a 7-point categorical scale that is used by a clinician to assess how much the patient's or participant?s illness has improved or worsened relative to a baseline state at the beginning of the study or intervention. It is a measure of symptom response to treatment, or change (e.g., progression) over time.
N/A
1.00
2022-05-02 10:15:15.0
Parkinson's Disease
Parkinson's Disease
F3003-PD-MOTORFNC
Clinical Global Impression Scale-Severity (CGI-S)
The Clinical Global Impression Scale-Severity (CGI-S) is a 7-point categorical scale that requires the clinician to rate the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis.
N/A
1.00
2022-05-02 10:18:23.0
Parkinson's Disease
Parkinson's Disease
F3017-PD-OVRWGREC
Cognitive Subgroup Summary
Parkinson's Disease v2.0 Cognitive Subgroup Summary
N/A
1.00
2022-05-12 09:55:30.0
Parkinson's Disease
Parkinson's Disease
F2959-PD-COGNITVE
Cogstate Brief Battery
Cogstate Brief Battery contains four tests: One-Back (attention and working memory), One Card Learning (visual learning and memory), Identification (visual attention) and Detection (processing speed).
N/A
1.00
2022-04-29 14:00:11.0
Parkinson's Disease
Parkinson's Disease
F1930-PD-PSYCHFNC
Columbia - Suicide Severity Rating Scale (C-SSRS)
The Columbia - Suicide Severity Rating Scale (C-SSRS) is a widely used instrument across research, clinical and institutional settings that was developed to assess suicidal ideation and behavior and is available in over 100 languages.
N/A
1.00
2015-02-10 15:37:25.0
Parkinson's Disease
Parkinson's Disease
F2996-PD-PSYCHFNC
Columbia - Suicide Severity Rating Scale (C-SSRS) Screener Version
The screen version of the Columbia - Suicide Severity Rating Scale (C-SSRS) contains a total of 6 possible yes or no questions that assess suicidal ideation and behavior over the past month. Results triage respondents into low, moderate, and high risk categories.
N/A
1.00
2015-02-10 15:37:25.0
Parkinson's Disease
Parkinson's Disease
F1659-PD-OTHNONMT
Composite Autonomic Symptom Scale (COMPASS-31)
Composite Autonomic Symptom Scale (COMPASS-8) (COMPASS-31)
N/A
1.00
2013-11-14 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F2178-PD-PSYCHFNC
Compulsive Eating Scale (CES)
The Compulsive Eating Scale (CES) is a 32-item self-report questionnaire that measures the degree of compulsive eating. Items in the CES include "emotional states related to food and eating as well as information with regard to weight, weight control, height, and eating binge.
N/A
1.00
2016-06-09 14:42:18.0
Parkinson's Disease
Parkinson's Disease
F2179-PD-OTHNONMT
Constipation Severity Scale (CSS)
The Constipation Severity Scale is an ordinal symptom frequency scale that is calculated as a sum of a 5-point ordinal frequency ratings for the six Rome III (IV) functional constipation questions. The Rome III (IV) CSS is a consistent measure that augments the diagnostic utility of the Rome III (IV) constipation criteria and reflects the degree of quality of life impairment.
N/A
1.00
2016-06-09 14:46:33.0
Parkinson's Disease
Parkinson's Disease
F3004-PD-MOTORFNC
Core Assessment Program for Surgical Interventional Therapies in PD (CAPSIT-PD)
Core Assessment Program for Surgical Interventional Therapies in PD (CAPSIT-PD) is a patient diary that assesses motor fluctuations in Parkinson's disease. It was developed for use in patients undergoing surgery but is also applicable to non-surgical programs and places special interest on the differentiation of OFF from partial-OFF periods.
N/A
1.00
2022-05-02 10:20:10.0
Parkinson's Disease
Parkinson's Disease
F2997-PD-PSYCHFNC
Cornell Scale for Depression in Dementia (CSDD)
The Cornell Scale for Depression in Dementia (CSDD) is a 19-item clinician interview of the caregiver and patient. It is used as a screening tool to measure depression symptoms and signs over the past week. This scale was designed for use in geriatric patients with moderate to severe impairment.
N/A
1.00
2022-05-02 09:24:45.0
Parkinson's Disease
Parkinson's Disease
F2944-PD-DEM
Demographics
Contains data elements that are collected to describe the demographics of the study population relevant to Parkinson's disease research. (Examples of CDEs included: General CDE demographic elements (sex assigned at birth, gender identity, race, ethnicity, etc.); date of birth)
CDE Details
2.00
2022-06-30 13:56:05.0
Parkinson's Disease
Parkinson's Disease
F1660-PD-PSYCHFNC
Diagnostic and Statistical Manual of Mental Disorders (DSM-5)
N/A
1.00
2013-11-14 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F3018-PD-OVRWGREC
Digital Technology Subgroup Summary
Parkinson's Disease v2.0 Digital Technology Subgroup Summary
N/A
1.00
2022-05-12 09:55:30.0
Parkinson's Disease
Parkinson's Disease
F2991-PD-PSYCHFNC
Dimensional Apathy Scale (DAS)
The Dimensional Apathy Scale (DAS) is a 24 item self-report scale that measures apathy over the last month in three subscales: executive (lack of motivation for organization, planning, or attention), emotional (lack of emotional motivation, indifference or emotional neutrality), and initiation (lack of motivation for self-generation of thought and or/actions).
N/A
1.00
2022-04-29 16:38:00.0
Parkinson's Disease
Parkinson's Disease
F2992-PD-PSYCHFNC
Dimensional Apathy Scale (DAS) Informant/Carer-Rated Version
The Dimensional Apathy Scale (DAS) is a 24 item caregiver reported scale that measures apathy over the last month in three subscales: executive (lack of motivation for organization, planning, or attention), emotional (lack of emotional motivation, indifference or emotional neutrality), and initiation (lack of motivation for self-generation of thought and or/actions).
N/A
1.00
2022-04-29 16:41:34.0
Parkinson's Disease
Parkinson's Disease
F2180-PD-OTHNONMT
Drooling Rating Scale (DRS)
The DRS evaluates drooling in multiple situations including while sitting, standing, while in bed, talking, and eating and drinking.
N/A
1.00
2016-06-09 14:49:55.0
Parkinson's Disease
Parkinson's Disease
F0785-PD-OTHNONMT
Drooling Severity and Frequency Scale (DSFS)
The Drooling Severity and Frequency Scale (DSFS) is a semi-quantitative assessment of the amount of drooling.
N/A
1.00
2012-05-11 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F2993-PD-PSYCHFNC
Enhanced Scale for the Assessment of Positive Symptoms in Parkinson's Disease (eSAPS-PD)
The enhanced Scale for the Assessment of Positive Symptoms in PD (eSAPS) is a structured clinical interview and is an expanded version of the SAPS-PD with additional questions related to delusions (i.e. Capgras syndrome and other delusions), hallucinations (i.e. olfactory, gustatory) and minor hallucinations (i.e. illusions, passage and presence hallucinations).
N/A
1.00
2022-04-29 16:44:30.0
Parkinson's Disease
Parkinson's Disease
F3019-PD-OVRWGREC
Epidemiology and Environment Subgroup Summary
Parkinson's Disease v2.0 Epidemiology and Environment Subgroup Summary
N/A
1.00
2022-05-12 09:55:30.0
Parkinson's Disease
Parkinson's Disease
F3030-PD-OTHNONMT
Epworth Sleepiness Scale (ESS) - Adult Version
CDE Details
1.00
2013-08-13 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F3029-PD-QUALLIFE
EuroQoL-5 Dimension Questionnaire (EQ-5D)
Standardized measure of health status developed by the EuroQol Group in order to provide a simple, generic measure of health for clinical and economic appraisal
CDE Details
1.00
2012-04-10 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F2948-PD-GENHLTHX
Family History
Contains data elements that determine if Parkinson's disease or other related neurological diseases/disorders run in the participant's/ subject's immediate family. (Examples of CDEs included: Number of Family Members; Number with PD or Parkinsonism; Number with Other Neurological Disorder; etc.)
CDE Details
1.10
2012-08-10 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F0786-PD-OTHNONMT
Fatigue Severity Scale (FSS)
The Fatigue Severity Scale (FSS) is a nine-item questionnaire that assesses the effect of fatigue on daily living.
N/A
1.00
2012-05-11 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F2965-PD-OTHNONMT
Female Sexual Function Index (FSFI)
The Female Sexual Function Index (FSFI) is a widely used, brief, and self-reported measure used for the screening and diagnosis of female sexual function. The 6-domain structure covers desire, subjective arousal, lubrication, orgasm, satisfaction, and pain through 19 questions.
N/A
1.00
2022-04-29 14:24:36.0
Parkinson's Disease
Parkinson's Disease
F0787-PD-EPENHIST
Food Frequency Questionnaire (FFQ)
The Food Frequency Questionnaire (FFQ) consists of a list of foods with little descriptive detail, and the respondent answers questions about the frequency of each food on the list.
N/A
1.00
2012-05-11 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F3020-PD-OVRWGREC
Functional Neurosurgery Subgroup Summary
Parkinson's Disease v2.0 Functional Neurosurgery Subgroup Summary
N/A
1.00
2022-05-12 09:55:30.0
Parkinson's Disease
Parkinson's Disease
F2952-PD-SURGOTHR
Functional Neurosurgery: Deep Brain Stimulation
Contains data elements about pre-, intra-, and post-operative guidelines for DBS reports. (Examples of CDEs included: Head Position; Intraoperative Target Verification; L-dopa challenge responses; etc.)
CDE Details
1.10
2012-08-10 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F0804-PD-PSYCHFNC
Gambling Symptom Assessment Scale (G-SAS)
Contains data elements used to evaluate gambling symptoms. (Examples of CDEs included: Urges to Gamble; Thoughts on Gambling; Emotional distress over gambling; etc.)
N/A
1.00
2012-06-25 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F2966-PD-OTHNONMT
Gastrointestinal Symptoms in Neurodegenerative Diseases Scale (GIND)
Gastrointestinal Symptoms in Neurodegenerative Diseases Scale (GIND) assesses the severity of GI symptoms in Parkinson's disease. It covers all of the GI symptoms known to occur in PD (drooling, dysphagia, heartburn, reflux, nausea, vomiting, anorexia, early satiety, bloating, abdominal pain, gas, stool frequency, stool consistency, defecatory dysfunction, and weight loss) as well as the impact of these symptoms on mood and activities of daily living.
N/A
1.00
2022-04-29 14:26:36.0
Parkinson's Disease
Parkinson's Disease
F3021-PD-OVRWGREC
General and Motor Subgroup Summary
Parkinson's Disease v2.0 General and Motor Subgroup Summary
N/A
1.00
2022-05-12 09:55:30.0
Parkinson's Disease
Parkinson's Disease
F1807-PD-DEM
General Core
Contains data elements for all of the general core CDEs and has been duplicated across all of the disorders on the NINDS CDE website. (Examples of CDEs included: Date of birth; Sex assigned at birth; Gender identity; Race; Ethnicity; Education; SNOMED CT code)
CDE Details
1.00
2014-08-11 13:44:58.0
Parkinson's Disease
Parkinson's Disease
F3022-PD-OVRWGREC
Genetics Subgroup Summary
Parkinson's Disease v2.0 Genetics Subgroup Summary
N/A
1.00
2022-05-12 09:55:30.0
Parkinson's Disease
Parkinson's Disease
F3013-PD-DIGTTECH
Guidance for Digital Data Sharing
Guidance for digital data sharing for clinical trials on Parkinson's disease summarizing the type of metadata, technology and environment information that should be included when uploading Digital Health Data to a database
N/A
1.00
2022-05-09 11:52:16.0
Parkinson's Disease
Parkinson's Disease
F2171-PD-PSYCHFNC
Hamilton Anxiety Rating Scale (HAM-A)
Contains data elements which rate the severity of the participant/subject's level of anxiety. (Examples of CDEs included: Anxious mood; Tension; Fears; etc.)
CDE Details
1.00
2012-06-25 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F0807-PD-PSYCHFNC
Hamilton Depression Rating Scale (HDRS)
Contains data elements which cumulatively rate the participant/subject's level of depression. (Examples of CDEs included: Insomnia; Feelings of Guilt; Agitation; etc.)
N/A
1.00
2012-06-25 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F3005-PD-MOTORFNC
Hauser Motor Fluctuation Diary
Hauser Motor Fluctuation Diary is a patient completed diary of his/her status (includes the categories asleep, OFF, ON without dyskinesia, ON with nontroublesome dyskinesia, and ON with troublesome dyskinesia) during preset intervals (normally half hour) over a 24-h period, and should be completed for each period at the end of that interval. It is applicable to surgical and non-surgical protocols or clinical management and places special emphasis on the differentiation of troublesome from non-troublesome dyskinesia.
N/A
1.00
2022-05-02 10:30:59.0
Parkinson's Disease
Parkinson's Disease
F2945-PD-EPENHIST
History of Early Exposure
Contains data elements about the history of being breast fed, sibship/birth order, and preschool attendance. (Examples of CDEs included: Did you attend preschool; Numbers of brothers and sisters; Did your mother breastfeed you; etc.)
CDE Details
1.10
2012-08-10 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F3006-PD-MOTORFNC
Hoehn and Yahr Scale
The Hoehn and Yahr (HY) scale is the most widely used and universally accepted staging system for overall functional disability of Parkinson's disease, applied in clinical care and research. It is a categorical staging system that mixes two concepts of disability and impairment: unilaterality vs. bilaterality and absence vs. presence of balance impairment.
N/A
1.00
2022-05-02 10:40:21.0
Parkinson's Disease
Parkinson's Disease
F1266-PD-PSYCHFNC
Hospital Anxiety and Depression Scale (HADS)
The Hospital Anxiety and Depression Scale (HADS) is a 14-item self-report scale that consists of a depression and an anxiety scale, each with 7 items. The scale was designed to screen for mood disorders in general (non-psychiatric) medical outpatients. It focuses on subjective disturbances of mood rather than physical signs, and aims at distinguishing depression from anxiety. Compared to other instruments scales, it focuses on emotional aspects of anxiety disturbances, as opposed to somatic and cognitive symptoms.
N/A
1.00
2012-05-11 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F2967-PD-OTHNONMT
Hyposmia Rating Scale (HRS)
The Hyposmia Rating Scale (HRS) is a self-administered scale that reliably evaluates hyposmia in Parkinson's disease.
N/A
1.00
2022-04-29 14:30:03.0
Parkinson's Disease
Parkinson's Disease
F3015-PD-IMGDIAGN
Imaging Guidance for CDE Use
Guidance for Parkinson's disease imaging studies using an imaging tool specific approach; includes suggested analysis methods for some modalities
N/A
1.00
2011-02-28 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F3023-PD-OVRWGREC
Imaging Subgroup Summary
Parkinson's Disease v2.0 Imaging Subgroup Summary
N/A
1.00
2022-05-12 09:55:30.0
Parkinson's Disease
Parkinson's Disease
F2946-PD-EPENHIST
Infection History
Contains data elements about the participant/subject's history of influenza, pneumonia, and meningitis. (Examples of CDEs included: Age at time of pneumonia; First influenza vaccination; Age at time of meningitis; etc.)
CDE Details
1.10
2012-08-10 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F2968-PD-OTHNONMT
Innsbruck REM Sleep Behavior Disorder Inventory (RBD-I-5)
Innsbruck REM Sleep Behavior Disorder Inventory (RBD-I-5) is a five-item instrument designed to screen for the presence of REM Sleep Behavior Disorder. It assesses the presence and frequency of symptoms (violent/aggressive dream content, sleep-related vocalizations, sleep-related extensive movements, sleep-related injurious behaviors, and dream-behavior isomorphism).
N/A
1.00
2022-04-29 14:46:06.0
Parkinson's Disease
Parkinson's Disease
F0788-PD-OTHNONMT
Insomnia Severity Index (ISI)
Contains data elements that assess the participant/subject's insomnia severity. (Examples of CDEs included: Falling asleep; Staying asleep; Sleep pattern; etc.)
N/A
1.00
2012-06-25 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F1663-PD-OTHNONMT
International Consultation on Incontinence Modular Questionnaire-Overactive Bladder (ICIQ-OAB)
N/A
1.00
2013-11-14 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F2969-PD-OTHNONMT
International Consultation on Incontinence Questionnaire (ICIQ) Bladder Diary
The International Consultation on Incontinence Questionnaire (ICIQ) bladder diary records a patient?s urinary frequency, volume voided, fluid intake (amount, time, type), bladder sensation and pad use over a 3-day period. This validated diary can be used in clinical practice for the assessment of lower urinary tract symptoms (LUTS).
N/A
1.00
2022-04-29 15:00:52.0
Parkinson's Disease
Parkinson's Disease
F1665-PD-OTHNONMT
International Index of Erectile Function-5 (IIEF-5)
N/A
1.00
2013-11-14 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F1666-PD-OTHNONMT
International Prostate Symptom Scale (IPSS)
N/A
1.00
2013-11-14 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F1680-PD-OTHNONMT
International Restless Legs Syndrome Study Group Severity Rating Scale (IRLS)
N/A
1.00
2013-11-14 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F1667-PD-OTHNONMT
Karolinska Sleepiness Scale (KSS)
N/A
1.00
2013-11-14 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F2970-PD-OTHNONMT
King's Parkinson's Disease Pain Questionnaire (KPPQ)
The King?s Parkinson?s Disease Pain Questionnaire (KPPQ) is the patient self-administered version of the King?s Parkinson?s Disease Pain Scale (KPPS) which was developed to evaluate the multiple pain modalities present in Parkinson's disease.
N/A
1.00
2022-04-29 15:03:42.0
Parkinson's Disease
Parkinson's Disease
F2971-PD-OTHNONMT
King's Parkinson's Disease Pain Scale (KPPS)
The King?s Parkinson?s Disease Pain Scale (KPPS) was developed to evaluate the multiple pain modalities present in Parkinson's disease, administered by health professionals. It assesses the severity and frequency of pain across seven domains: musculoskeletal, chronic, fluctuating, nocturnal, orofacial, edematous, radicular.
N/A
1.00
2022-04-29 15:05:41.0
Parkinson's Disease
Parkinson's Disease
F2398-PD-PSYCHFNC
Lille Apathy Rating Scale (LARS)
The Lille Apathy Rating Scale (LARS) is a structured, standardized interview questionnaire designed to distinguish between the various features of apathy.
N/A
1.00
2017-03-08 10:55:40.0
Parkinson's Disease
Parkinson's Disease
F2960-PD-COGNITVE
Lumos Labs NeuroCognitive Performance Tests (NCPT)
The Lumos Labs NeuroCognitive Performance Tests (NCPT) is a brief, repeatable, web-based platform of cognitive assessments. It measures functioning across cognitive domains including working memory, visuospatial memory, psychomotor speed, fluid and logical reasoning, response inhibition, numerical calculation, and selective and divided attention.
N/A
1.10
2022-06-13 15:47:12.0
Parkinson's Disease
Parkinson's Disease
F1668-PD-COGNITVE
Mattis Dementia Rating Scale (MDRS)
N/A
1.00
2013-11-14 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F2972-PD-OTHNONMT
Mayo Sleep Questionnaire (MSQ)
Mayo Sleep Questionnaire (MSQ) consists of 16 items designed to screen for the presence of a wide range of sleep disorders (e.g., REM sleep behavior disorder (RBD), periodic limb movements of sleep (PLMS), restless legs syndrome (RLS)). MSQ is designed to be completed by caregivers/bed partners.
N/A
1.00
2022-04-29 15:09:37.0
Parkinson's Disease
Parkinson's Disease
F1681-PD-PSYCHFNC
McElroy Diagnostic Criteria for Compulsive Buying
N/A
1.00
2013-11-14 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F2949-PD-HISDISIN
Medical History of Parkinson's Disease
Contains data elements related to the study participant's/ subject's health history when Parkinson's disease was first diagnosed. Particular attention is paid to motor symptoms. (Examples of CDEs included: Diagnostic features/criteria; Initial Motor Symptoms; etc.)
CDE Details
1.10
2012-08-10 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F0789-PD-OTHNONMT
Mini Nutritional Assessment (MNA)
The MNA? is a validated nutrition screening and assessment tool that can identify geriatric patients age 65 and above who are malnourished or at risk of malnutrition.
N/A
1.00
2012-05-11 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F1669-PD-COGNITVE
Mini-Mental State Examination (MMSE)
The Mini-Mental State Examination (MMSE) is a brief, global cognitive rating scale that was developed to identify cognitive status in adults. It covers orientation, repetition, verbal recall, attention and calculation, language, and visual construction.
N/A
1.00
2013-11-14 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F1670-PD-PSYCHFNC
Montgomery-Asberg Depression Scale (MADRS)
The Montgomery-Asberg Depression Rating Scale (MADRS) is a 10-item rater-administered assessment tool that is most often used in clinical trials of antidepressants to select patients with a diagnosis of depression for the study and to assess efficacy of the treatment. Ratings are based on the patient's condition in the past week.
N/A
1.00
2013-11-14 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F1469-PD-COGNITVE
Montreal Cognitive Assessment (MoCA)
The Montreal Cognitive Assessment MoCA was designed to efficiently screen for mild to moderate cognitive impairment, including patients with normal mini-mental state examination (MMSE). It screens eight domains: Visuospatial/executive, Naming, Memory, Attention, Language, Abstraction, Delayed recall, and Orientation. Alternate forms are available to mitigate practice effects across serial assessments.
N/A
1.00
2013-05-16 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F0778-PD-MOTORFNC
Movement Disorder Society - Unified Parkinson's Disease Rating Scale (MDS-UPDRS)
Contains data elements about non-motor and motor features of Parkinson's disease. This is the new version of the UPDRS sponsored by the MDS. (Examples of CDEs included: Non-motor examination; Motor examination; etc.)
N/A
1.00
2011-02-28 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F3007-PD-MOTORFNC
Movement Disorder Society Clinical Diagnostic Criteria for Parkinson's Disease
The Movement Disorder Society Clinical Diagnostic Criteria for Parkinson's Disease (PD) instrument includes criteria for clinically established PD and clinically probable PD. Exclusion criteria are defined that would suggest an alternate cause of parkinsonism. Red flags are proposed that must be factored in to determine level of certainty in the diagnosis.
N/A
1.00
2022-05-02 10:44:25.0
Parkinson's Disease
Parkinson's Disease
F2950-PD-IMGDIAGN
MRI and Spectroscopy
Contains data elements used in imaging studies to visualize internal structures. (Examples of CDEs included: Pre-scan actions; Site of Visual Analysis; etc.)
CDE Details
1.10
2012-08-10 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F0790-PD-OTHNONMT
Multiple Sleep Latency Test (MSLT) and Guidelines
Contains recommendations used in the assessment and diagnosis of excessive somnolence and evaluation of excessive daytime sleepiness.
N/A
1.00
2011-02-28 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F2973-PD-OTHNONMT
Munich Dysphagia Test - Parkinson's Disease (MDT-PD)
The Munich Dysphagia Test ? Parkinson?s Disease (MDT-PD) is a 26-item patient-reported outcome questionnaire for early diagnosis of dysphagia in patients with Parkinson?s disease. It includes subscales addressing four areas: Difficulty swallowing food and liquids (10 items), Difficulty swallowing independent from food intake (4 items), Further swallowing-specific and accompanying burden (9 items), and Swallowing-specific health questions (3 items).
N/A
1.00
2022-04-29 15:29:20.0
Parkinson's Disease
Parkinson's Disease
F2957-PD-OTHCLDTA
National Alzheimer's Coordinating Center (NACC) Neuropathology Data Form
The National Alzheimer's Coordinating Center (NACC) Neuropathology Data Form is used to collect a selected set of pathological features at autopsy.
N/A
1.00
2022-04-29 13:51:21.0
Parkinson's Disease
Parkinson's Disease
F1463-PD-NIHRSRCE
National Institutes of Health (NIH) Toolbox
The National Institutes of Health Toolbox is a collection of brief, comprehensive assessment tools that will be useful in a variety of settings with a particular emphasis on measuring outcomes in epidemiologic studies and clinical trials across the lifespan. The batteries include various cognitive (episodic memory, language, processing speed, working memory, executive functions, attention), emotional (negative affect, positive affect, stress and coping, social relationships), sensory (vestibular, audition, olfaction, taste, vision) and motor functions (dexterity, strength, locomotion, endurance, balance).
N/A
1.00
2013-05-16 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F2855-PD-OTHNONMT
Neurogenic Bladder Symptom Score (NBSS)
The Neurogenic Bladder Symptom Score (NBSS) (24-item) and the Neurogenic Bladder Symptom Score short form (NBSS-SF) (10-item) are both freely available, self-administered, questionnaires that assesses urinary symptoms and bladder-related consequences in patients with acquired or congenital neurogenic bladder dysfunction as a result of spinal cord injury, multiple sclerosis, and spinal bifida.
N/A
1.00
2021-10-25 10:24:28.0
Parkinson's Disease
Parkinson's Disease
F3024-PD-OVRWGREC
Neuropathology Subgroup Summary
Parkinson's Disease v2.0 Neuropathology Subgroup Summary
N/A
1.00
2022-05-12 09:55:30.0
Parkinson's Disease
Parkinson's Disease
F2998-PD-PSYCHFNC
Neuropsychiatric Inventory (NPI)
The Neuropsychiatric Inventory (NPI) is a clinician administered, caregiver reported interview assessing patient behavioral disturbances occurring in dementia. Ten domains are measured; delusions, hallucinations, dysphoria, anxiety, agitation/aggression, euphoria, disinhibition, irritability/lability, apathy, and aberrant motor activity. The 12-item version also includes sleep/night time behavior changes and appetite/eating changes.
N/A
1.00
2022-05-02 09:29:32.0
Parkinson's Disease
Parkinson's Disease
F2961-PD-COGNITVE
NeuroTrax BrainCare
The NeuroTrax BrainCare is a cloud-based computerized cognitive assessment application. Domains include memory, attention, executive function, visuospatial skills, verbal function, information processing, and motor skills.
N/A
1.10
2022-06-09 09:20:44.0
Parkinson's Disease
Parkinson's Disease
F0772-PD-LABSBIOM
NINDS Repository Parkinsonism Data Elements
N/A
1.00
2012-08-10 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F0014-PD-OTHNONMT
Non-Motor Symptom Questionnaire (NMS-Quest) (PD-NMS)
N/A
1.00
2012-08-23 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F2953-PD-DRUGS
Non-Parkinson's Disease Medication Log
Contains data elements about the participant/subject's non-PD medication history during study enrollment. (Examples of CDEs included: Macroscopic aspects; Alzheimer's type pathology; Lewy body pathology; etc.)
CDE Details
1.10
2012-08-10 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F2947-PD-EPENHIST
Non-prescribed Drug Use Questionnaire
Contains data elements about use of drugs not prescribed by a doctor in the participant/subject's lifetime. (Examples of CDEs included: Year of First Use; Last Year Used; Total Years Used; Frequency of Use; etc.)
CDE Details
1.10
2012-08-10 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F1671-PD-OTHNONMT
Numeric Rating Scale (NRS)-Box 21 Scale
N/A
1.00
2013-11-14 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F1682-PD-EPENHIST
Nurses' Health Study Questionnaire (NHQ)
N/A
1.00
2013-11-14 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F0770-PD-EPENHIST
Ohio State University TBI Identification Method Short Form
Ohio State University TBI Identification Method-Short Form (OSU TBI-ID-SF) is a shortened version of a structured interview developed using recommendations from the CDC for the detection of history of exposure to traumatic brain injury. It elicits self- or proxy-reports of TBI occurring over a person's lifetime according to selected summary indices.
N/A
1.00
2012-05-11 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F2974-PD-OTHNONMT
Orthostatic Hypotension Questionnaire (OHQ)
The Orthostatic Hypotension Questionnaire (OHQ) is a validated scale to assess the comprehensive symptom burden and severity of neurogenic orthostatic hypotension. It is comprised of two components: a six-item symptom assessment scale (OHSAS) and a four-item daily activity scale (OHDAS) to assess the burden of symptoms.
N/A
1.00
2022-04-29 15:31:53.0
Parkinson's Disease
Parkinson's Disease
F2975-PD-OTHNONMT
Orthostatic Symptom Grading Scale
The Orthostatic Symptom Grading Scale is a self-report orthostatic rating scale that assesses frequency of orthostatic symptoms, severity, conditions under which symptoms occur, interference with activities of daily living, and ability for stand for periods of time.
N/A
1.00
2022-04-29 15:34:07.0
Parkinson's Disease
Parkinson's Disease
F3048-PD-OTHNONMT
Other Non-Motor Guidance for CDE Use
Contains a summary of the subgroup process in determining the instruments and elements they recommended for other non-motor studies in Parkinson's disease.
CDE Details
1.00
2022-07-29 09:27:06.0
Parkinson's Disease
Parkinson's Disease
F3025-PD-OVRWGREC
Other Non-Motor Subgroup Summary
Parkinson's Disease v2.0 Other Non-Motor Subgroup Summary
N/A
1.00
2022-05-12 09:55:30.0
Parkinson's Disease
Parkinson's Disease
F2399-PD-PSYCHFNC
Parkinson Anxiety Scale (PAS)
The Parkinson Anxiety Scale (PAS) is a 12-item observer or patient-rated scale with three subscales, for persistent anxiety, episodic anxiety, and avoidance behavior, that provides a reliable measurement of the severity of anxiety symptoms in Parkinson's patients.
N/A
1.00
2017-03-08 11:15:01.0
Parkinson's Disease
Parkinson's Disease
F2962-PD-DAYCOGFX
Parkinson's Disease - Cognitive Functional Rating Scale (PD-CFRS)
The Parkinson's Disease - Cognitive Functional Rating Scale (PD-CFRS) assesses the functional aspects of cognitive impairment in Parkinson's disease. It includes 12 questions about activities of daily living (e.g., handling money, controlling medication regimen, using public transportation).
N/A
1.00
2022-04-29 14:13:02.0
Parkinson's Disease
Parkinson's Disease
F2976-PD-OTHNONMT
Parkinson's Disease Fatigue Scale (PFS-16)
The Parkinson's Disease Fatigue Scale (PFS-16) was designed to tap a single construct encompassing the physical aspects of fatigue and their impact on the patient?s daily function. The scale deliberately excludes emotional and cognitive features that may occur as part of the fatigue experience, but which may also occur independently in Parkinsonism.
N/A
1.00
2022-04-29 15:37:15.0
Parkinson's Disease
Parkinson's Disease
F2955-PD-LABSBIOM
Parkinson's Disease Genetics
Contains data elements collecting information on the genetic etiology of participants with Parkinson?s disease/parkinsonism. The focus is on variables related to sample processing and genetic testing results while also capturing some information on variables related to phenotype in both the clinical and research setting.
CDE Details
1.00
2022-04-29 12:49:12.0
Parkinson's Disease
Parkinson's Disease
F2954-PD-DRUGS
Parkinson's Disease Medication Log
Contains data elements about current non-study PD medications the participant/ subject has taken in his/her lifetime. Study PD medications should not be listed on this CRF. (Examples of CDEs included: Medication prior or concomitant name; Medication prior or concomitant route type; Medication prior or concomitant daily dose frequency; etc.)
CDE Details
1.10
2012-08-10 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F1685-PD-QUALLIFE
Parkinson's Disease Quality of Life Questionnaire (PDQL)
N/A
1.00
2013-11-14 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F1420-PD-QUALLIFE
Parkinson's Disease Quality of Life Scale (PDQUALIF)
Contains data elements related to non-motor symptoms of PD. (Examples of CDEs included: balance, exercise, social activities, and sleep).
N/A
1.00
2012-10-15 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F1673-PD-QUALLIFE
Parkinson's Disease Questionnaire (PDQ-39)
N/A
1.00
2013-11-14 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F0007-PD-OTHNONMT
Parkinson's Disease Sleep Scale 2nd Version (PDSS-2)
N/A
1.00
2012-08-23 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F2672-PD-COGNITVE
Parkinson's Disease-Cognitive Rating Scale (PD-CRS)
The Parkinson?s Disease-Cognitive Rating Scale (PD-CRS) was developed to ?capture the whole spectrum of cognitive functions impaired over the course of PD.?
N/A
1.00
2017-06-29 11:27:55.0
Parkinson's Disease
Parkinson's Disease
F0815-PD-QUALLIFE
Parkinson's Impact Scale (PIMS)
The 10 item scale measures the impact of Parkinson's disease. This disease specific measure can be completed by the subject or by an interviewer. It is intended for a patient but has been validated in caregivers as well. It has four domains: physical aspects of disease (5 items), psychological aspects (2 items), social aspects (2 items) and sexuality (2 items).
N/A
1.00
2012-05-11 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F2994-PD-PSYCHFNC
Parkinson's Psychosis Questionnaire (PPQ)
The Parkinson's Psychosis Questionnaire (PPQ) is a screening tool for early detection of psychosis in PD. It measures the frequency and severity of four domains: sleep disturbances, hallucinations/illusions, delusions, and orientation. It was developed to screen early drug-induced psychosis in PD.
N/A
1.00
2022-04-29 16:46:08.0
Parkinson's Disease
Parkinson's Disease
F2995-PD-PSYCHFNC
Parkinson's Psychosis Rating Scale (PPRS)
The Parkinson's Psychosis Rating Scale (PPRS) is a 6-item (visual hallucinations, illusions/misidentification, paranoid ideation, sleep disturbance, confusion, and sexual preoccupation) clinician rated scale that measures the severity of psychosis symptoms in PD patients.
N/A
1.00
2022-04-29 16:47:52.0
Parkinson's Disease
Parkinson's Disease
F2191-PD-PSYCHFNC
Pathological Gambling Adaptation of the Yale-Brown Obsessive Compulsive Scale (PG-YBOCS)
The Pathological Gambling version of the Yale-Brown Obsessive Compulsive Scale (PG-YBOCS) is a 10-item clinician-administered scale that measures the severity of pathological gambling within a set period of time (i.e., the past one / two week(s)).
N/A
1.00
2016-06-15 11:49:45.0
Parkinson's Disease
Parkinson's Disease
F2999-PD-PSYCHFNC
Patient Health Questionnaire - 2 (PHQ-2)
The Patient Health Questionnaire - 2 (PHQ-2) is a screening tool that is specific for depression. It includes the initial two items of the PHQ-9, which assess for presence and frequency of depressed mood (feeling down or hopeless) and anhedonia (loss of interest or pleasure) over the prior two weeks.
N/A
1.00
2022-05-02 09:41:42.0
Parkinson's Disease
Parkinson's Disease
F3028-PD-PSYCHFNC
Patient Health Questionnaire - 9 (PHQ-9) Depression Scale
PHQ-9 provides a reliable and valid measure of depression severity and also yields a DSM-IV criteria based diagnosis of a depressive disorder. This 9 item measure asks subjects whether and how often they have been bothered by depression related symptoms over the last two weeks, ranging from not at all (0) to nearly every day (3). Based on total score, depression severity ranges from minimal symptoms (5-9) to greater than 20 indicating severe major depression.
CDE Details
2.00
2012-06-28 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F1647-PD-NIHRSRCE
Patient-Reported Outcomes Measurement Information System (PROMIS)
The Patient Reported Outcomes Measurement Information System (PROMIS) contains calibrated item banks with Likert style items for approximately 70 domains (e.g., anger, anxiety, depression, fatigue, pain, physical function, satisfaction with social activities and roles, sleep/wake disturbance, and global health). PROMIS measures cover physical, mental, and social health and can be used across chronic conditions.
N/A
1.00
2013-10-29 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F1345-PD-OTHNONMT
Pelli Robson Test
Measures contrast sensitivity using a single large letter size (20/60 optotype), with contrast varying across groups of letters
N/A
1.00
2012-04-10 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F2963-PD-DAYCOGFX
Penn Parkinson's Daily Activities Questionnaire-15 (PDAQ-15)
The Penn Parkinson's Daily Activities Questionnaire-15 (PDAQ-15) is an item-response theory-based questionnaire that assesses cognitive instrumental activities of daily living (IADL) in Parkinson's disease patients across the cognitive spectrum.
N/A
1.00
2022-04-29 14:16:21.0
Parkinson's Disease
Parkinson's Disease
F2951-PD-IMGDIAGN
PET-SPECT Localization
Contains data elements used to measure cellular/tissue change in a participant/subject. (Examples of CDEs included: Radioligand; Quantitative Imaging Outcome; etc.)
CDE Details
1.00
2022-07-22 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F3014-PD-EPENHIST
PhenX Social Determinants of Health Guidance
Guidance document on the measures available from the PhenX Social Determinants of Health collection of protocols.
N/A
1.00
2022-05-09 11:52:16.0
Parkinson's Disease
Parkinson's Disease
F3043-PD-OTHNONMT
Pittsburgh Sleep Quality Index (PSQI)
The Pittsburgh Sleep Quality Index is a self-rated questionnaire that primarily assesses nighttime sleep problems. It focuses on sleep experiences over the past month. It has 19 self-rated questions and 5 additional questions for a bed partner or roommate.
CDE Details
1.00
2012-05-11 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F2977-PD-OTHNONMT
Polysomnography (PSG) and Guidelines
Polysomnography (PSG) consists of the joint evaluation of brain activity (electroencephalogram, EEG), eye movements (electro-oculogram, EOG), and muscle tone (electromyography, EMG). By studying these three variables, wakefulness sleep and its different sleep stages (N1 or dozing, N2 or light sleep, N3 or deep sleep and REM sleep) can be distinguished.
N/A
1.00
2022-04-29 15:39:46.0
Parkinson's Disease
Parkinson's Disease
F3056-PD-QUALLIFE
PROMIS Item Bank v1.2 - Global Health
The PROMIS Scale v1.2 - Global Health (also referred to as PROMIS-10) is a ten-item patient reported measure of physical, mental and social health.
CDE Details
1.00
2017-04-07 14:54:54.0
Parkinson's Disease
Parkinson's Disease
F2833-PD-QUALLIFE
PROMIS-29 Profile
A profile measure designed for adults that includes physical function, fatigue, pain interference, pain intensity, sleep disturbance, depression, anxiety, and ability to participate in social activities short forms for Stroke.
N/A
1.00
2020-05-15 15:17:36.0
Parkinson's Disease
Parkinson's Disease
F3026-PD-OVRWGREC
Psychiatry Subgroup Summary
Parkinson's Disease v2.0 Psychiatry Subgroup Summary
N/A
1.00
2022-05-12 09:55:30.0
Parkinson's Disease
Parkinson's Disease
F3000-PD-PSYCHFNC
Psychosis and Hallucinations Questionnaire (PsycH-Q)
The Psychosis and Hallucinations Questionnaire (PsycH-Q) is a 20 item self-report questionnaire to detect psychosis phenomena and associated symptoms falling into 5 categories: visual misperceptions, sensory misperceptions, disordered thought, attentional dysfunction, and sleep impairment. It was developed for use in Parkinson's disease.
N/A
1.00
2022-05-02 09:57:09.0
Parkinson's Disease
Parkinson's Disease
F1462-PD-NIHRSRCE
Quality of Life in Neurological Disorders (Neuro-QOL)
Quality of Life in Neurological Disorders (Neuro-QOL) is a measurement system designed for neurologically impaired populations that includes patient reported outcomes of functioning, such as social, psychological, and mental well-being. Item banks cover the following domains: Lower Extremity Function-Mobility, Upper Extremity Function-Fine Motor, ADL, Depression, Anxiety, Positive Affect and Well-Being, Stigma, Cognitive Function, Social Role Performance, Satisfaction with Social Roles and Activities, Fatigue, Emotional and Behavioral Dyscontrol, and Sleep Disturbance.
N/A
1.00
2013-05-16 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F1462-PD-QUALLIFE
Quality of Life in Neurological Disorders (Neuro-QOL)
Quality of Life in Neurological Disorders (Neuro-QOL) is a measurement system designed for neurologically impaired populations that includes patient reported outcomes of functioning, such as social, psychological, and mental well-being. Item banks cover the following domains: Lower Extremity Function-Mobility, Upper Extremity Function-Fine Motor, ADL, Depression, Anxiety, Positive Affect and Well-Being, Stigma, Cognitive Function, Social Role Performance, Satisfaction with Social Roles and Activities, Fatigue, Emotional and Behavioral Dyscontrol, and Sleep Disturbance.
N/A
1.00
2013-05-16 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F1029-PD-OTHNONMT
Quality of Life in Swallowing Disorders (SWAL-QOL)
Contains data elements for the Quality of Life in Swallowing Disorders (SWAL-QOL) [Examples of CDEs included: Dealing with my swallowing problem is very difficult; My swallowing problem is a major distraction in my life]
N/A
1.00
2012-08-31 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F3027-PD-OVRWGREC
Quality of Life Subgroup Summary
Parkinson's Disease v2.0 Quality of Life Subgroup Summary
N/A
1.00
2022-05-12 09:55:30.0
Parkinson's Disease
Parkinson's Disease
F0809-PD-PSYCHFNC
Questionnaire about Buying Behavior (QABB)
The Buying Questionnaire is a 19-item self-rated questionnaire that measures severity of buying behaviors.
N/A
1.00
2012-03-23 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F0018-PD-PSYCHFNC
Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease (QUIP) (Long Form)
N/A
1.00
2012-08-23 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F0019-PD-PSYCHFNC
Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease (QUIP) (Short Form)
N/A
1.00
2012-08-23 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F2400-PD-PSYCHFNC
Questionnaire Impulsive-Compulsive Disorders Parkinson's Disease-Rating Scale (QUIP-RS)
The Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease-Rating Scale (QUIP-RS) quantifies the severity of a variety of compulsive disorders and behaviors reported to occur in Parkinson?s disease (PD); supports a diagnosis of impulse control disorders or behaviors (ICDs); and monitors changes in patient?s ICD symptom severity with time, including response to treatment.
N/A
1.00
2017-03-08 11:31:12.0
Parkinson's Disease
Parkinson's Disease
F2978-PD-OTHNONMT
Radboud Oral Motor Inventory for Parkinson's Disease (ROMP)
The Radboud Oral Motor Inventory for Parkinson?s Disease (ROMP) is a self-reported questionnaire. It screens for abnormalities of speech, swallowing, saliva control and it measures the physical and psychosocial impact of each domain.
N/A
1.00
2022-04-29 15:41:21.0
Parkinson's Disease
Parkinson's Disease
F1220-PD-EPENHIST
Risk Factor Questionnaire (RFQ) - NSAIDS and Calcium Channel Blockers (CCB)
Contains data elements about use of NSAIDS and Calcium Channel Blockers. (Examples of CDEs included: Ages/years regularly taken ibuprofen-based, non-aspirin medications; Treated for conditions requiring prescription for calcium channel blockers; etc.)
N/A
1.00
2012-05-11 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F2169-PD-EPENHIST
Risk Factor Questionnaire (RFQ) - Occupation and Employment Status
Contains data elements about occupation and employment status of the participant/subject during different phases of life. (Examples of CDEs included: Military history; Occupation history from birth-25 years, 26-35 years, 36-45 years, 46-55 years, 56-65 years, and 66 years and above; etc.)
CDE Details
1.00
2012-05-11 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F0762-PD-EPENHIST
Risk Factor Questionnaire (RFQ) - Physical Activity and Sleep
Contains data elements about types of physical activity and amount of sleep the participant/subject received during different phases of life. (Examples of CDEs included: Physical activity and sleep hours from 12-17 years, 18-25 years, 26-35 years, 36-45 years, 46-55 years, 56-65 years, and 66 years and above; etc.)
N/A
1.00
2011-02-28 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F1218-PD-EPENHIST
Risk Factor Questionnaire (RFQ) - Residential History
Contains data elements about the participant/subject's current and past residences during different periods of life. (Examples of CDEs included: Residence from birth-17 years, 18-25 years, 26-35 years, 36-45 years, 46-55 years, 56-65 years, and 66 years and above; Pesticide spraying at residence; etc.)
N/A
1.00
2012-05-11 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F1221-PD-EPENHIST
Risk Factor Questionnaire (RFQ) - Toxicants
Contains data elements about the participant/subject's exposure to different categories of toxicants at work and at home. (Examples of CDEs included: Use of glues or adhesives, solvents or degreasers, flame cut, weld, or braze metals, soldered, and, metal dust or metal fumes; etc.)
N/A
1.00
2012-05-11 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F1217-PD-EPENHIST
Risk Factor Questionnaire (RFQ-U) - Height and Weight
Contains data elements about the participant's/subject's height, weight, and body type at 3 different age periods. (Examples of CDEs included: Height and weight at 25 years, 40 years, and 60 years; etc.)
N/A
1.10
2012-10-15 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F1223-PD-EPENHIST
Risk Factor Questionnaire (RFQ-U) - Pesticides (Home)
Contains data elements about the participant/subject's lifetime pesticide exposure at work and home. (Examples of CDEs included: Exposure to pesticides in different work environments from birth-25 years, 26-35 years, 36-45 years, 46-55 years, 56-65 years, and 66 years and above; etc.)
N/A
1.00
2012-05-11 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F1222-PD-EPENHIST
Risk Factor Questionnaire (RFQ-U) - Pesticides (Work)
Contains data elements about the participant/subject's lifetime pesticide exposure at work and home. (Examples of CDEs included: Exposure to pesticides in different work environments from birth-25 years, 26-35 years, 36-45 years, 46-55 years, 56-65 years, and 66 years and above; etc.)
N/A
1.00
2012-05-11 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F1219-PD-EPENHIST
Risk Factor Questionnaire (RFQ-U) - Smoking and Tobacco
Contains data elements about the participant/subject's smoking use and habits. (Examples of CDEs included: Ages/years regularly smoked; Cigarettes smoked per day; Use of other tobacco products; etc.)
N/A
1.00
2012-05-11 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F0792-PD-OTHNONMT
Rome III/IV Constipation Module
This questionnaire was developed to assist physicians, health care professionals and researchers in identifying individuals who have one or more functional gastrointestinal disorders (FGIDs).
N/A
2.00
2022-08-09 18:27:07.0
Parkinson's Disease
Parkinson's Disease
F3008-PD-MOTORFNC
Rush Dyskinesia Rating Scale (RDRS)
The Rush Dyskinesia Rating Scale (RDRS) is a disability assessment and was developed and clinimetrically tested prior to its 2013 presentation. The RDRS is a clinician rated outcome and assesses the severity of dyskinesia based on interference from dyskinesia during three standardized motor tasks.
N/A
1.00
2022-05-02 10:55:35.0
Parkinson's Disease
Parkinson's Disease
F0794-PD-OTHNONMT
Scale for Outcomes in Parkinson's Disease Autonomic (SCOPA-AUT)
Contains data elements that assess the extent in the past month the participant/subject has had problems with bodily functions. (Examples of CDEs included: Difficulty swallowing; Difficulty passing urine; Excessive sweating; etc.)
N/A
1.00
2012-05-11 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F3040-PD-OTHNONMT
Scale for Outcomes in Parkinson's Disease-Sleep (SCOPA-SLEEP)
The SCOPA-S (Scale for Outcomes of Parkinson's disease-Sleep) is a self-rated questionnaire developed originally for research in Parkinson's disease that addresses both nighttime sleep problems and daytime sleepiness. Its questions focus on experiences over the past month. It has two questions on the use of sleeping medications, one question on an overall global perception of sleep at night, 6 questions on sleep patterns at night and 6 questions on sleep in the day.
CDE Details
1.00
2012-05-11 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F0810-PD-PSYCHFNC
Scale for the Assessment of Positive Symptoms (SAPS)
Contains data elements which are used to assess positive symptoms such as hallucinations, delusions, bizarre behavior, and positive formal thought disorder that occur primarily in schizophrenia. (Examples of CDEs included: Hallucinations; Delusions; Bizarre Behavior; etc.) .
N/A
1.00
2012-06-25 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F2401-PD-PSYCHFNC
Scale for the Assessment of Positive Symptoms-Parkinson's Disease (SAPS-PD)
The SAPS-PD is a shortened version of the original SAPS scale which includes a subset of questions from the hallucinations and delusions subdomains (SAPS-H+D) indicative of those symptoms most commonly seen in a PDP patient population
N/A
1.00
2017-03-08 11:56:08.0
Parkinson's Disease
Parkinson's Disease
F0775-PD-COGNITVE
Scales for Outcomes in Parkinson's Disease-Cognitive (SCOPA-COG)
Contains data elements to assess specific aspects of cognitive function in Parkinson's disease. (Examples of CDEs included: Memory and Function; Attention; Executive Functions; etc.)
N/A
1.00
2012-05-11 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F0816-PD-QUALLIFE
Scales for Outcomes in Parkinson's Disease-Psychosocial (SCOPA-PS)
The Scales for Outcomes in PD-Psychological (SCOPA-PS) measures psychosocial functioning in PD.
N/A
1.00
2012-05-11 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F1686-PD-QUALLIFE
Schedule for the Evaluation of Individual Quality of Life (SEIQoL)
N/A
1.10
2022-06-06 15:08:15.0
Parkinson's Disease
Parkinson's Disease
F1590-PD-QUALLIFE
Schedule for the Evaluation of Individual Quality of Life - Direct Weighting (SEIQoL-DW)
N/A
1.00
2013-09-16 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F3009-PD-MOTORFNC
Schwab and England Activities of Daily Living Scale
The Schwab and England Activities of Daily Living Scale estimates the abilities of individuals living with a disease relative to a range of life activities spanning from a bedridden, vegetative state (the lowest score of 0%) to complete independence of function (the highest score of 100%).
N/A
1.00
2022-05-02 11:02:26.0
Parkinson's Disease
Parkinson's Disease
F2956-PD-EPENHIST
Secondhand Smoke Microenvironment Questionnaire
The Secondhand Smoke Microenvironment Questionnaire is a ten-item questionnaire designed to measure self-reported involuntary smoke exposure in the work, home, and social spheres.
N/A
1.00
2022-04-29 13:45:52.0
Parkinson's Disease
Parkinson's Disease
F0811-PD-PSYCHFNC
Sexual Compulsivity Scale (SCS)
The Sexual Compulsivity Scale is a 10-item self-rated questionnaire that assesses tendencies toward sexual preoccupation.
N/A
1.00
2012-06-25 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F2170-PD-QUALLIFE
Short Form 36-Item Health Survey (SF-36)
Contains data elements for the SF-36 instrument [Examples of CDEs included: In general would you say your health is and compared to one year ago, how would you rate your health in general now]"
CDE Details
1.00
2011-05-01 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F0796-PD-OTHNONMT
Sialorrhea Clinical Scale for Parkinson's Disease (SCS-PD)
The Sialorrhea Clinical Scale for PD (SCS-PD) assesses drooling severity and frequency as well as social and functional impairment from drooling.
CDE Details
1.00
2012-05-14 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F2979-PD-OTHNONMT
Sniffin' Sticks Test
The Sniffin' Sticks Test provides complete olfactory assessment by applying a perception threshold test, an odor discrimination test, and an odor identification test.
N/A
1.00
2022-04-29 15:44:20.0
Parkinson's Disease
Parkinson's Disease
F0812-PD-PSYCHFNC
South Oaks Gambling Screen (SOGS)
The South Oaks Gambling Screen (SOGS) is a self-rated screening questionnaire and is the most commonly used instrument to screen for pathological or problem gambling in the general population.
N/A
1.00
2012-05-11 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F0798-PD-OTHNONMT
Stanford Sleepiness Scale (SSS)
Contains data elements that assess how alert the participant/subject is feeling. (Examples of CDEs included: Feeling active, alert; Functioning at high levels; etc.)
N/A
1.00
2012-06-25 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F2980-PD-OTHNONMT
STOP-BANG Questionnaire
The STOP-BANG Questionnaire is an 8-item self-administered questionnaire that assesses the risk of obstructive sleep apnea. It includes 8 questions related to snoring, daytime sleepiness, stopped breathing during sleep, and hypertension. The acronym represents the way the questions are presented: Snoring, Tired, Observed, Blood Pressure (STOP) and Body Mass Index, Age, Neck size, Gender (BANG).
N/A
1.00
2022-04-29 15:47:10.0
Parkinson's Disease
Parkinson's Disease
F3016-PD-PSYCHFNC
Summary of Diagnostic Criteria and Assessments for Psychosis in Parkinson's Disease
Guidance on the diagnostic criteria and assessment of psychosis in Parkinson's disease
N/A
1.00
2011-02-28 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F0015-PD-OTHNONMT
Swallowing Disturbance Questionnaire (SDQ)
N/A
1.00
2012-08-23 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F1654-PD-OTHNONMT
The American Academy of Sleep Medicine (AASM): International Classification of Sleep Disorders (ICSD) Criteria
N/A
1.00
2013-11-14 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F2981-PD-OTHNONMT
The Gastrointestinal Dysfunction Scale for Parkinson's Disease
The Gastrointestinal Dysfunction Scale for Parkinson?s Disease is a patient-reported, questionnaire-based assessment of GI symptoms. It includes questions about stool frequency (both increased and decreased), straining during defecation, stool consistency, incomplete evacuation, abdominal pain, bloating, weight loss, dysphagia, drooling, heartburn, and nausea.
N/A
1.00
2022-04-29 15:59:51.0
Parkinson's Disease
Parkinson's Disease
F1661-PD-OTHNONMT
The International Association for the Study of Pain (IASP) Definitions for Pain
N/A
1.00
2013-11-14 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F2982-PD-OTHNONMT
The International Parkinson and Movement Disorder Society - Non-Motor Rating Scale (MDS-NMS)
The International Parkinson and Movement Disorder Society - Non-Motor Rating Scale (MDS-NMS) is a revised version of the Non-Motor Symptoms Scale (NMSS). It is a rater-completed assessment of non-motor symptoms in Parkinson?s disease (PD). Frequency and severity of PD and treatment related non-motor symptoms are measured across 13 non-motor domains.
N/A
1.00
2022-04-29 16:02:36.0
Parkinson's Disease
Parkinson's Disease
F3055-PD-OTHNONMT
The International Parkinson and Movement Disorder Society - Non-Motor Rating Scale (MDS-NMS) (GI Domain)
The International Parkinson and Movement Disorder Society - Non-Motor Rating Scale (MDS-NMS) is a revised version of the Non-Motor Symptoms Scale (NMSS). It is a rater-completed assessment of non-motor symptom frequency and severity in Parkinson?s disease (PD). Domain 10 (or "J") of the MDS-NMS scale covers the GI tract. There are 4 GI symptoms covered: drooling, swallowing, nausea, and constipation.
N/A
1.00
2022-04-29 16:02:36.0
Parkinson's Disease
Parkinson's Disease
F1664-PD-OTHNONMT
The International Restless Legs Syndrome Study Group Diagnostic Criteria
N/A
1.00
2013-11-14 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F2984-PD-OTHNONMT
The REM Sleep Behavior Disorder (RBD) Questionnaire - Hong Kong (RBDQ-HK)
The REM Sleep Behavior Disorder (RBD) Questionnaire - Hong Kong (RBDQ-HK) consists of 13 items designed to assess various symptoms that correspond to two essential clinical aspects of RBD - dream-related features and behavioral manifestation. Each item is rated on two scales - lifetime occurrence and recent one-year frequency.
N/A
1.00
2022-04-29 16:10:01.0
Parkinson's Disease
Parkinson's Disease
F1675-PD-OTHNONMT
The REM Sleep Behavior Disorder (RBD) Screening Questionnaire (RBDSQ)
N/A
1.00
2013-11-14 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F2983-PD-OTHNONMT
The REM Sleep Behavior Disorder Single-Question Screen (RBD1Q)
The REM Sleep Behavior Disorder Single-Question Screen (RBD1Q) is a single self-administered question with a ?yes? or ?no? response: ?Have you ever been told, or suspected yourself that you seem to ?act out your dreams? while asleep (for example, punching, flailing your arms in the air, making running movements, etc.)??.
N/A
1.00
2022-04-29 16:06:26.0
Parkinson's Disease
Parkinson's Disease
F2985-PD-OTHNONMT
The Swallowing Clinical Assessment Score in Parkinson's Disease (SCAS-PD)
The Swallowing Clinical Assessment in PD (SCAS-PD) aims to identify the occurrence of specific alterations of each phase of swallowing (oral, pharyngeal, and laryngotracheal) giving the patient 3 different consistencies of food: 20 ml liquid (water), 10 ml paste (liquid with pudding consistency), and one unit solid (salt cracker).
N/A
1.00
2022-04-29 16:12:51.0
Parkinson's Disease
Parkinson's Disease
F1678-PD-MOTORFNC
UK Parkinson's Disease Society Brain Bank Criteria for the Diagnosis of Parkinson's Disease
N/A
1.00
2013-11-14 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F3010-PD-MOTORFNC
Unified Dyskinesia Rating Scale (UDysRS)
The Unified Dyskinesia Rating Scale (UDysRS) has four parts: I) Historical Disability (patient perceptions) of On-Dyskinesia impact; II) Historical Disability (patient perceptions) of Off-Dystonia impact; III) Objective Impairment (Dyskinesia severity, anatomical distribution over seven body regions, and type (choreic or dystonic) based on four activities observed or video-recorded; IV) Objective Disability based on Part III activities.
N/A
1.00
2022-05-02 11:04:54.0
Parkinson's Disease
Parkinson's Disease
F0779-PD-MOTORFNC
Unified Parkinson's Disease Rating Scale (UPDRS)
Contains data elements about non-motor and motor features of Parkinson's disease. (Examples of CDEs included: Non-motor examination; Motor examination; etc.)
N/A
1.00
2012-05-11 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F1676-PD-OTHNONMT
University of Pennsylvania Smell Identification Test (UPSIT)
N/A
1.00
2013-11-14 00:00:00.0
Parkinson's Disease
Parkinson's Disease
F2986-PD-OTHNONMT
Visual Impairment in Parkinson's Disease Questionnaire (VIPD-Q)
The Visual Impairment in Parkinson's Disease Questionnaire (VIPD-Q) assesses ophthalmologic symptoms across 4 domains according to structures: (1) ocular surface; (2) intraocular; (3) oculomotor; and (4) optic nerve.
N/A
1.00
2022-04-29 16:19:02.0
Parkinson's Disease
Parkinson's Disease
F3011-PD-MOTORFNC
Wearing Off Questionnaire (WOQ)
The Wearing Off Questionnaire (WOQ) is a screening tool to quantify the change of "wearing-off" (a predictable recurrence of motor and nonmotor symptoms preceding scheduled doses of antiparkinsonian medication).
N/A
1.00
2022-05-02 11:08:01.0
Parkinson's Disease
Parkinson's Disease
F0817-PD-QUALLIFE
World Health Organization Quality of Life Assessment (WHOQOL-BREF)
The WHOQOL-BREF was developed as short version of the WHOQOL-100 for use in situations where time is restricted, where respondent burden must be minimized and where detail is less necessary e.g. large epidemiologic surveys and some clinical trials.
N/A
1.00
2012-05-11 00:00:00.0
Parkinson's Disease
Parkinson's Disease